Search Results - "Lewi, David S"

Imbalance between endothelial progenitors cells and microparticles in HIV-infected patients naive for antiretroviral therapy by DA SILVA, Erika F. R, FONSECA, Francisco A. H, FRANCA, Carolina N, FERREIRA, Paulo R. A, IZAR, Maria C. O, SALOMAO, Reinaldo, CAMARGO, Luciano M, TENORE, Simone B, LEWI, David S

“…Cardiovascular events have been reported among HIV-infected patients following antiretroviral therapy. However, the role of HIV itself in determining vascular…”
Get full text

Primary antiretroviral drug resistance among HIV type 1-infected individuals in Brazil by Sprinz, Eduardo, Netto, Eduardo M, Patelli, Maria, Lima, J S, Lima, Maria Patelli J S, Furtado, Juvênao J D, da Eira, Margareth, Zajdenverg, Roberto, Madruga, José V, Lewi, David S, Machado, Alcyone A, Pedro, Rogério J, Soares, Marcelo A

“…Infection with drug-resistant human immunodeficiency virus type 1 (HIV-1) has been documented in all countries that have surveyed for it and may result in an…”
Get more information

Safety and immunovirologic outcomes with maraviroc combination regimens in patients with a history of past treatment failures and virologic resistance in Brazil: an open-label, multicenter phase 3b study by Furtado, Juvencio, Madruga, José V, Bicudo, Eliana L, da Eira, Margareth, Lopes, Max I B F, Netto, Eduardo M, Santini-Oliveira, Marília, Leite, Olavo H M, Machado, Alcyone A, Tupinambas, Unaí, de Andrade Neto, José L, Lima, Maria P J S, Pedro, Rogério de Jesus, Miranda, Antônio F B, Lewi, David S, Santos, Breno R, Portsmouth, Simon, Wajsbrot, Dalia B, Cassoli, Lourenia M

“…Maraviroc is a first-in-class chemokine coreceptor type-5 (CCR5) antagonist with demonstrated immunovirologic activity in treatment-experienced (TE) patients…”
Get more information

Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine by HAAS, David W, ARATHOON, Eduardo, BENETUCCI, Jorge, CAHN, Pedro, PAAR, David, WHITE, A. Clinton, COLLIER, Ann C, RAMIREZ-RONDA, Carlos H, HARVEY, Charlotte, CHUNG, Mi-Ok, MEHROTRA, Devan, CHODAKEWITZ, Jeffrey, THOMPSON, Melanie A, NGUYEN, Bach-Yen, PEDRO, Rogiero De, GALLANT, Joel E, UIP, David E, CURRIER, Judith, NORIEGA, L. Miguel, LEWI, David S, URIBE, Patricia

“…To compare the efficacy and safety of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine. Two multicenter,…”
Get full text

Randomized, double-blind trial comparing indinavir alone, zidovudine alone and indinavir plus zidovudine in antiretroviral therapy-naive HIV-infected individuals with CD4 cell counts between 50 and 250/mm3 by Lewi, D S, Suleiman, J M, Uip, D E, Pedro, R J, Souza, R A, Suleiman, G S, Accetturi, C, Leite, O M, Abreu, W B, Kalichman, A O, Moraes-Filho, J P, Motti, E F, Pecoraro, M L, Makurath, M R, Nessly, M L, Leavitt, R Y

“…Treatment with indinavir has been shown to result in marked decreases in viral load and increases in CD4 cell counts in HIV-infected individuals. A randomized…”
Get full text

Randomized, double-blind trial comparing indinavir alone, zidovudine alone and indinavir plus zidovudine in antiretroviral therapy-naive HIV-infected individuals with CD4 cell by Lewi, David S, Suleiman, Jamal M, Uip, David E, Pedro, Rogerio J, Souza, Rosa A

“…Treatment with indinavir has been shown to result in marked decreases in viral load and increases in CD4 cell counts in HIV-infected individuals. A randomized…”
Get full text